alexa [Systemic tolerance of corticosteroid therapy in ophthalmology depending on the route of administration].
Ophthalmology

Ophthalmology

Journal of Clinical & Experimental Ophthalmology

Author(s): FeldmanBillard S, Hron E

Abstract Share this page

Abstract Corticosteroids have been a major therapeutic improvement, particularly in ophthalmology. Depending on the different therapeutic modalities used, the ophthalmologist will mainly encounter a risk of short-term adverse effects (intravenous administration, high doses, etc.) or a risk of long-term side effects (related to the cumulative dose received). In any case, the underlying status of each patient must be carefully assessed in order to choose the best individual treatment modalities that will minimize the risk of undesirable effects. Intravitreal and topical steroid administrations do not seem to be associated with a significant risk of systemic adverse effects, because blood diffusion of the product is minimal. Conversely, periocular injections lead to a rapid and nearly total systemic diffusion of the steroid, with hyperglycemic effects similar to those observed after intravenous pulse methylprednisolone. Thus, periocular and intravenous routes of administration carry similar risks of systemic effects and both cases require similar monitoring, with strict blood glucose monitoring useful in diabetic patients only. The various systemic complications of long-term oral steroid therapy can be reduced by always prescribing the minimal efficient dosage for controlling the disease, together with preventive measures against adverse effects when possible, e.g., the prevention of corticosteroid-induced osteoporosis. In the future, new glucocorticoids or agonists, e.g., the dissociated glucocorticoids or SEGRAs (SElective Glucocorticoid-Receptor Agonists), now in clinical development, should further reduce the risk of adverse effects of steroids while maintaining their remarkable anti-inflammatory action.
This article was published in J Fr Ophtalmol and referenced in Journal of Clinical & Experimental Ophthalmology

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords